Methods and compositions for efficient nucleic acid sequencing

• US 7,070,927 B2
• Filed: 02/05/2002
• Issued: 07/04/2006
• Est. Priority Date: 09/27/1993
• Status: Expired due to Fees

• Current Assignee: University of Chicago
• Original Assignee: University of Chicago
• Inventors: Drmanac, Radoje
• Primary Examiner(s): Horlick, Kenneth R.
• Assistant Examiner(s): Wilder, Cynthia B.
• Application Number:
  US10/068,301
• Publication Number:
  US 20020197621A1
• Time in Patent Office: 1,610 Days
• Field of Search: 435/6, 435/7.1, 435/91.1, 435/91.2, 435/287.1, 536/22.1, 536/23.1, 536 243- 2433
• US Class Current: 435/6.12
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation

Abstract

Disclosed are novel methods and compositions for rapid and highly efficient nucleic acid sequencing based upon hybridization with two sets of small oligonucleotide probes of known sequences. Extremely large nucleic acid molecules, including chromosomes and non-amplified RNA, may be sequenced without prior cloning or subcloning steps. The methods of the invention also solve various current problems associated with sequencing technology such as, for example, high noise to signal ratios and difficult discrimination, attaching many nucleic acid fragments to a surface, preparing many, longer or more complex probes and labelling more species.

Claims

1. A method of determining a nucleotide sequence of a target nucleic acid, comprising the steps of:

(a) contacting a target nucleic acid with a set of immobilized oligonucleotide probe(s) and at least one labeled oligonucleotide probe from a set of labeled oligonucleotide probes under hybridization conditions effective to permit hybridization between;

(i) complementary sequences of the target nucleic acid and the immobilized probes and (ii) complementary sequences of the target nucleic acid and the labeled probe(s);

(b) covalently joining immobilized probe(s) and labeled probe(s) which are adjacently hybridized to the same target nucleic acid molecule;

(c) detecting the labels of the labeled oligonucleotide probe(s) that are covalently joined to the immobilized probe(s);

(d) identifying at least one nucleotide sequence in the target nucleic acid by steps comprising connecting the nucleotide sequences of the detected labeled oligonucleotide probe(s) with the nucleotide sequences of their respective joined immobilized oligonucleotide probe(s)

(e) analyzing the sequences identified in step (d) to determine identified sequences that overlap and

(f) reconstructing said sequence from overlapping oligonucleotide sequences identified in step (e).

2. A method according to claim 1 wherein the set of immobilized oligonucleotide probes comprises a first set of immobilized oligonucleotide probes and the at least one labeled oligonucleotide probe comprises a first labeled oligonucleotide probe, the method further comprising the step of, between steps a) and b):

contacting the target nucleic acid with a second set of immobilized oligonucleotide probe(s) and a second labeled oligonucleotide probe under hybridization conditions effective to permit hybridization between;

(i) complementary sequences of the target nucleic acid and the immobilized probes of the second set and (ii) complementary sequences of the target nucleic acid and the second labeled oligonucleotide probe, wherein the first and second labeled oligonucleotide probes comprise different nucleotide sequences and the labels of the first and second labeled oligonucletide probes are the same.

3. The method of claim 1 wherein said labels are detected in situ.

4. The method of claim 1, wherein said covalently joining immobilized probe(s) and labeled probe(s) comprises contacting said probes with a ligating agent.

5. The method of claim 4 wherein said labeled probe(s) are contacted with the target nucleic acid at the same time as said ligating agent.

6. The method of claim 1, wherein after step (b) and before step (c), labeled probes that are not covalently joined to an immobilized probe are removed.

7. The method of claim 1 in which labeled probes that are not covalently joined to an immobilized probe are removed under stringent washing conditions.

8. The method of claim 1 in which a plurality of immobilized probes are immobilized on the same support.

9. The method of claim 1 in which immobilized probes having different nucleotide sequences are immobilized on different supports.

10. The method of claim 1 in which the immobilized oligonucleotide probes comprises a plurality of arrays arranged in the form of a sequencing chip.

11. The method of claim 2 in which a plurality of immobilized probes of the first set are immobilized on a support and/or a plurality of immobilized probes of the second set are immobilized on the same support.

12. The method of claim 11 in which the first and second sets of immobilized probes comprise a sequencing chip.

13. The method of claim 2 in which immobilized probes of the first set having different nucleotide sequences are immobilized on different supports and/or immobilized probes of the second set having different nucleotide sequences are immobilized on different supports.

14. The method of claim 1 in which in step (a), the target nucleic acid is contacted with a set of labeled oligonucleotide probes in a sequential manner, one labeled oligonucleotide probe at a time.

15. The method of claim 14 in which in step (a), labeled oligonucleotide probes of the set which have different nucleotide sequences are labeled with the same label.

16. The method of claim 14 in which in step (a), at least two labeled oligonucleotide probes of the set which have different nucleotide sequences are labeled with different labels.

17. The method of claim 14 in which in step (a), the target nucleic acid is contacted simultaneously with the set of immobilized probes and the labeled oligonucleotide probe.

18. The method of claim 14 in which in step (a), the target nucleic acid is contacted first with the set of immobilized probes to form immobilized probe:

target complexes and thereafter with the labeled oligonucleotide probe.

19. The method of claim 1 in which in step (a), the target nucleic acid is contacted simultaneously with at least two labeled oligonucleotide probes of a set of labeled oligonucleotide probes, wherein said at least two labeled oligonucleotide probes are labeled with different, distinguishable labels and have different nucleotide sequences that are identifiable by the properties of their respective labels.

20. The method of claim 19 in which in step (a), the target nucleic acid is contacted simultaneously with the set of immobilized probes and said at least two labeled oligonucleotide probes.

21. The method of claim 19 in which in step (a), the target nucleic acid is contacted first with the set of immobilized probes to form immobilized probe:

target complexes and thereafter with said at least two labeled oligonucleotide probes.

22. The method of claim 1 in which in step (a), the target nucleic acid is contacted simultaneously with at least two labeled oligonucleotide probes of a set of labeled oligonucleotide probes, wherein said at least two labeled oligonucleotide probes are labeled with different, distinguishable labels and have different nucleotide sequences that are identifiable by the properties of their respective labels and in step (d) the nucleotide sequences of the immobilized and labeled probes are determined by observing in situ the properties of the labels and their relative positions within an array.

23. The method of claim 22 in which in step (a), the target nucleic acid is contacted simultaneously with the array of immobilized probes and said at least two labeled oligonucleotide probes.

24. The method of claim 22 in which in step (a), the target nucleic acid is contacted first with the array of immobilized probes to form immobilized probe:

target complexes and thereafter with said at least two labeled oligonucleotide probes.

25. The method of claim 1, wherein the complete nucleotidle sequence of the target nucleic acid is determined.

26. The method of claim 1, wherein the target nucleic acid is mapped.

27. The method of claim 1, wherein the target nucleic acid is partially sequenced.

28. The method of claim 1, wherein the immobilized oligonucleotide probes have a length F and the labeled oligonucleotide probes have a length P, where F and P are each independently between 4 and 9 nucleotides.

29. The method of claim 1 wherein said immobilized oligonucleotide probe(s) and/or said labeled probe(s) additionally comprise a universal base or all four bases at the terminal position thereof.

30. The method of claim 1 wherein the target nucleic acid is fragmented prior to step (a).

31. The method of claim 30 wherein the target nucleic acid is fragmented by restriction enzyme digestion, ultrasound treatment, NaOH treatment or low pressure shearing.

32. The method of claim 30 wherein the target nucleic acid fragments have a length T, the immobilized oligonucleotide probes have a length F and the labeled oligonucleotide probes have a length P, where T is between 10 and 100 nucleotides and F and P are each independently between 4 and 9 nucleotides.

33. The method of claim 32 wherein T is between 10 and 40 nucleotides.

34. The method of claim 32 wherein T is about 20 nucleotides.

35. The method of claim 32 wherein T is about 3 times longer than F.

36. The method of any one of claims 32 through 35 wherein F and P are each 6 nucleotides.

37. The method of claim 1 wherein the adjacently hybridized immobilized and labeled probe(s) are covalently joined to one another by enzymatic ligation.

38. The method of any of claims 1 or 2 wherein the hybridization is carried out in cycles.

39. The method of any one of claims 1 or 2 wherein the hybridization conditions are effective to permit hybridization between target nucleic acids and only those immobilized probes and labeled probes that are perfectly complementary to a portion of the target.

40. The method of any one of claims 1 or 2 wherein the hybridization conditions are effective to permit hybridization between those immobilized probes and labeled probes that are immediately adjacent to each other and hybridize to the same target nucleic acid molecule.

41. The method of any one of claims 1 or 2 wherein the target nucleic acid is a cloned DNA, a chromosomal DNA or a mRNA.

42. The method of any one of claims 1 or 2 wherein the immobilized oligonucleotide probes are immobilized by way of covalent attachment.

43. The method of claim 42 wherein the immobilized probes are immobilized via a phosphodiester linkage.

44. The method of claim 42 wherein the immobilized probes are immobilized via a linker.

45. The method of any one of claims 1 or 2 wherein the immobilized probes are immobilized on glass, polystyrene or teflon.

46. The method of any one of claims 1 or 2 wherein the label is a radioactive isotope, non-radioactive isotope or a moiety that emits light.

47. The method of claim 42 wherein the label is a fluorescent dye.

48. The method of any one of claims 1 or 2 wherein the target nucleic acid, an immobilized probe or a labeled probe comprises a modified base or a universal base.

49. The method of any one of claims 1 or 2 wherein the immobilized probe contains a modification to allow the immobilized probe to be reused after said hybridization.

50. The method of claim 49 wherein the oligonucleotides of the labeled probe comprise ribonucleotides.

51. The method of claim 50 wherein said covalently joined labeled probe comprising ribonucleotides is removed from the immobilized probe by RNAase treatment.

52. The method of claim 49 wherein the covalently joined labeled probe comprises a uracil base.

53. The method of claim 52 wherein said covalently joined labeled probe comprising a uracil base is removed from the immobilized probe by uracil-DNA glycosylase treatment.

54. The method of claim 49 wherein said labeled probe comprises a chemically cleavable bond.